Clinical trial
A Phase 1 Study of PTC596 in Patients With Advanced Solid Tumors
NCT02404480 is registered in ClinicalTrials.gov with PTC Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1 Study of PTC596 in Patients With Advanced Solid Tumors
- Lead sponsor
- PTC Therapeutics
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 31, 2016
- Completion date
- February 6, 2017
- Enrollment
- 31 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
cancer